What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
Welcome to the IPC Psoriasis Masterclass for Asia, an exclusive educational opportunity for early- to mid-career dermatologists and other healthcare professionals actively managing and treating psoriasis.
This Masterclass is led by an esteemed faculty of international experts boasting extensive experience in psoriasis care. We aim to equip attendees with cutting-edge skills and knowledge to elevate their careers and become leaders in psoriasis.
IPC will provide travel stipends of $200 for local attendees and $500 for attendees traveling internationally.
Schedule:
Thursday, October 8–Laguna Garden Hotel, Paddle Bar Lounge, 13th Floor
19:00–20:30 – Welcome Reception
Friday, October 9–Okinawa Convention Center, Conference Room 2F B1, 2nd Floor
08:00 – Program Begins
17:30 – Program Ends
Limited Availability: Enrollment is limited to 50 participants, selected from applicants with a strong foundation in dermatology who are actively making treatment decisions and managing patients with psoriasis. All slots for attendees traveling internationally are now full. We are currently accepting applications only from individuals traveling within Japan.
Brief Summary of the Course
The IPC Psoriasis Masterclass for Asia is an intensive, eight-hour educational program designed for early-to-mid-career dermatologists and healthcare professionals interested in specializing in psoriasis care. With a focus on fostering a small group environment, the Masterclass provides a personalized learning experience, empowering participants to excel in their careers and become leaders in psoriasis.
The agenda has been carefully designed to ensure participants gain the skills and knowledge required to manage patients effectively. Participants will engage in dynamic discussions, interactive Q&A sessions, and invaluable networking opportunities with distinguished experts in the field.
Learning Outcomes
Topics Covered
Prerequisites
The IPC Psoriasis Masterclass is for early-mid career dermatologists and other health professionals with a strong foundation in dermatology who are making treatment decisions and managing patients with psoriasis.
REGISTRATION – 07:30
WELCOME + INTRODUCTION
Akimichi Morita, MD, PhD, Japan
Global and Regional Disease Burden of Psoriasis
Xiao-Yong Man, MD, PhD, China
Unveiling the Pathogenesis and Phenotypes of Psoriasis: A Bridge to Personalized Care
Emi Nishida, MD, PhD, Japan
Psoriasis as a Systemic Disease
Seong Jin Jo, MD, PhD, Republic of Korea
How to Assess Disease Severity and Treatment Outcomes in Clinical Practice
Pravit Asawanonda, MD, MSc, DSc, Thailand
BREAK
Optimizing the Use of Biologics and Biosimilars
Andrew Pink, PhD, United Kingdom
Phototherapy: Current Use and Developments
Akimichi Morita, MD, PhD, Japan
Optimizing the Use of Topicals and Oral Therapies
Peter van de Kerkhof, MD, PhD, Netherlands
Psoriatic Arthritis for Dermatologists
Yayoi Tada, MD, PhD, Japan
LUNCH
Treat-to-Target and Long-Term Psoriasis Management Strategy
Akimichi Morita, MD, PhD, Japan
Psoriasis in Special Populations & Circumstances
Yayoi Tada, MD, PhD, Japan
Challenging Cases Workshop – Presented by Delegates
BREAK
Faculty Forum: Challenging Cases
New and Emerging Treatments for Psoriasis
Seong Jin Jo, MD, PhD, Republic of Korea
Integrating the Lessons from the Masterclass
Closing Remarks
Akimichi Morita, MD, PhD, Japan
Seong Jin Jo, MD, PhD, Republic of Korea
Masterclass Location
Okinawa Convention Center
4 Chome-3-1 Mashiki, Ginowan,
Okinawa 901-2224, Japan
Conference Room 2F B1, 2nd Floor
Reception Location
Laguna Garden Hotel
4-Chome-1-1 Mashiki
Ginowan, Okinawa 901-2224, Japan
Paddle Bar Lounge, 13th Floor
Travel Scholarship
IPC is pleased to offer a travel scholarship to help offset accommodation and transportation costs. Attendees traveling from within Japan are eligible for a $200 scholarship. Please note that while the program is complimentary, participants are responsible for arranging their own travel and lodging.
Transportation
Participants are responsible for arranging and covering the cost of their air travel, ground transportation, and accommodations. We recommend booking flights well in advance to secure the best rates and to ensure your travel plans allow for full participation in the program.
The nearest airport to the venue, Okinawa Convention Center, is the Naha International Airport.
Meals
An evening reception with hors d’oeuvres and drinks will be held on Thursday, October 8, at the Laguna Garden Hotel Okinawa, 13th Floor Bar. Refreshments during breaks and lunch will be provided on Friday, October 9.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.